Prudential PLC Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Posted by Defense World Staff on May 19th, 2023

Prudential PLC bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,977 shares of the medical instruments supplier’s stock, valued at approximately $350,000.

Several other large investors have also recently made changes to their positions in XRAY. MetLife Investment Management LLC lifted its holdings in shares of DENTSPLY SIRONA by 23.1% during the first quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock valued at $2,926,000 after purchasing an additional 11,156 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in DENTSPLY SIRONA by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock worth $1,440,000 after acquiring an additional 1,811 shares during the last quarter. Raymond James Trust N.A. raised its holdings in DENTSPLY SIRONA by 61.7% in the 1st quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock worth $346,000 after acquiring an additional 2,687 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in DENTSPLY SIRONA by 6.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock worth $90,243,000 after acquiring an additional 117,571 shares during the last quarter. Finally, Sei Investments Co. raised its holdings in DENTSPLY SIRONA by 18.9% in the 1st quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock worth $23,090,000 after acquiring an additional 74,629 shares during the last quarter. 98.52% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

XRAY has been the subject of a number of recent analyst reports. TheStreet upgraded shares of DENTSPLY SIRONA from a “d+” rating to a “c” rating in a report on Tuesday, February 28th. Morgan Stanley boosted their price objective on shares of DENTSPLY SIRONA from $39.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, April 19th. The Goldman Sachs Group boosted their price objective on shares of DENTSPLY SIRONA from $34.00 to $39.00 and gave the stock a “neutral” rating in a report on Wednesday, March 1st. StockNews.com started coverage on shares of DENTSPLY SIRONA in a research report on Thursday. They issued a “buy” rating for the company. Finally, Robert W. Baird lifted their target price on shares of DENTSPLY SIRONA from $36.00 to $46.00 in a research report on Thursday, May 4th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $42.13.

Insider Activity

In related news, SVP Cord Friedrich Staehler sold 4,000 shares of the company’s stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total value of $157,320.00. Following the completion of the transaction, the senior vice president now owns 97,693 shares of the company’s stock, valued at approximately $3,842,265.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Eric Brandt sold 6,200 shares of the company’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total value of $261,454.00. Following the completion of the transaction, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Cord Friedrich Staehler sold 4,000 shares of the business’s stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total transaction of $157,320.00. Following the completion of the sale, the senior vice president now owns 97,693 shares in the company, valued at approximately $3,842,265.69. The disclosure for this sale can be found here. Insiders own 0.74% of the company’s stock.

DENTSPLY SIRONA Trading Up 0.9 %

Shares of XRAY stock opened at $40.50 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $26.48 and a 1 year high of $43.24. The firm has a fifty day moving average price of $39.69 and a 200-day moving average price of $35.70. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.93. The company has a market cap of $8.61 billion, a price-to-earnings ratio of 15.03, a PEG ratio of 2.30 and a beta of 0.91.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings data on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.05. DENTSPLY SIRONA had a negative net margin of 26.41% and a positive return on equity of 8.65%. The firm had revenue of $978.00 million during the quarter, compared to the consensus estimate of $938.16 million. During the same quarter in the previous year, the firm posted $0.52 EPS. The company’s revenue for the quarter was up .9% compared to the same quarter last year. As a group, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.91 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 14th. Stockholders of record on Friday, March 31st were given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend was Thursday, March 30th.

About DENTSPLY SIRONA

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.